Without comprehensive eating disorder treatment alongside medication, the risks may outweigh potential benefits
Sitagliptin alone accounts for approximately 15% of DPP-4 inhibitor prescriptions within the country and has been generally stable over the last few years
Various factors influence the effectiveness of Semaglutide GLP-1 in managing weight loss, including health and lifestyle factors, such as the patients metabolic rate, dietary habits, commitment to an exercise routine, stress management, and sleep cycles
The magnitude of improvement aligns with the 510% improvements in physical functioning typically observed in response to exercise interventions alone or as an add-on to calorie restriction [26, 40,41,42]
Customized dosing helps address this limitation